Ligand Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | (20.6) | (97.7) | (138.5) |
| Net Investing Cash Flow | (24.4) | 343.8 | 196.9 |
| Net Financing Cash Flow | (3.0) | (327.7) | 33.3 |
| Net Change in Cash | (48.1) | (81.6) | 91.6 |
| Depreciation & Amortization | 1.1 | 1.7 | 15.4 |
| Capital Expenditures | (0.5) | (0.4) | (1.8) |
| Cash Dividends Paid | 0.0 | (252.7) | -- |
© 2009 Morningstar, Inc. Financial Data provided by
